Newsbenzinga
White House Denies Report Linking Trump To Eli Lilly's Experimental Obesity Treatment: 'Not For The President'
· Published
Article summary
White House denies reports Trump received Eli Lilly's unapproved obesity drug retatrutide through an FDA program.
An excerpt from the original article.
Comments —
Loading comments…